Feb. 5, 2004 — Orla Protein Technologies Ltd., a Newcastle, England-based nanobiotechnology company, raised $513,000 in a second round of funding, according to a news release.
null
The funds came from Insight Capital, a specialist venture capital division of regional fund management firm Northern Enterprise Ltd.
null
The company will use the funds to continue technical and commercial development in engineered protein interfaces for applications in drug discovery, diagnostics, electronics and other areas.
null
The company also announced that Dale Athey became managing director and Frank Roberts was named chairman.